Get access

Rosiglitazone for type 2 diabetes mellitus

  • Protocol
  • Intervention

Authors

  • B Richter,

  • E Bandeira-Echtler,

  • K Bergerhoff,

  • C Clar,

  • SH Ebrahim


Dr Bernd Richter, Coordinating Editor 'Metabolic and Endocrine Disorders Cochrane Review Group', Department of Endocrinology, Diabetes and Rheumatology, Universitaetsklinikum Duesseldorf, Moorenstr. 5, Duesseldorf, 40225, GERMANY. richterb@uni-duesseldorf.de.

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effects of rosiglitazone in the treatment of type 2 diabetes.